Offering comprehensive coverage of this fast-changing field for more than 20 years, Urologic Surgical Pathology is an expert guide to all common and rare entities in the genitourinary system. The 4th Edition keeps you fully up to date with discussions of newly recognized tumors and terminologies, the latest classification schemes, current grading approaches, molecular alterations, and commonly used ancillary diagnostic techniques. With its clinical focus on day-to-day urological pathology sign-out and an emphasis on clinicopathologic and radiographic-pathologic correlations, this thoroughly revised uropathology reference is an excellent resource for diagnostic decision making.

• Includes expanded coverage of differential diagnosis for all tumor types encountered in urological surgical pathology practice.
• Incorporates the latest TNM staging and WHO classification systems, as well as new diagnostic biomarkers and their utility in differential diagnosis, newly described variants and new histologic entities.
• Discusses advances in molecular diagnostic testing, its capabilities, and its limitations, including targeted therapy/personalized medicine.
• Covers new developments in immunohistochemistry and the latest diagnostic tumor markers.
• Features more than 1,600 high-quality images - all in color - including gross pictures, histopathologic and cytopathologic images, special stains, other ancillaries, drawings, and illustrations.
• Helps you find information quickly with a consistent chapter format; an abundance of tables, diagrams and flowcharts; boxed lists of types and causes of diseases; differential diagnosis; characteristic features of diseases; complications; classifications; and staging.

Dr. Cheng has been the Principal Investigator (PI) and a Co-PI of more than ten grants supported by national and state agencies, as well as industry and foundation, in research areas of distributed sensing and computing and system instrumentation and analytics, with major applications in infrastructure and environment monitoring and the Internet of Things. Dr. Cheng has authored/co-authored more than 90 peer-reviewed papers, including a best paper, a best paper award nomination, and papers in premium conference/journals. He has been invited to serve on proposal panels for programs of NSF, DOE, NIH (National Institute of Health), GENI (Global Environment for Network Innovations), and as an expert reviewer for ACS (American Chemical Society), NRI (Nebraska Research Initiative), and research foundations in Europe.